Skip to contentZ
Zivo Bioscience, Inc.
Z
ZIVOZivo Bioscience, Inc. Q2 2018 · 10-Q
Revenue$0.00$0.00— vs Q2 2017 Net Income-$3.57M-$3.57MN/M vs Q2 2017 EPS Diluted-$0.02-$0.02N/M vs Q2 2017 Operating Income-$1,335,157N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Zivo Bioscience, Inc. · CIK 1101026 · Engraved from SEC EDGAR
derived
ended Jun 30, 2018 · filed Aug 14, 2018 · 45 d after period end